JPH0557273B2 - - Google Patents

Info

Publication number
JPH0557273B2
JPH0557273B2 JP63200928A JP20092888A JPH0557273B2 JP H0557273 B2 JPH0557273 B2 JP H0557273B2 JP 63200928 A JP63200928 A JP 63200928A JP 20092888 A JP20092888 A JP 20092888A JP H0557273 B2 JPH0557273 B2 JP H0557273B2
Authority
JP
Japan
Prior art keywords
substance
culture
present
starch
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP63200928A
Other languages
English (en)
Japanese (ja)
Other versions
JPH01131177A (ja
Inventor
Yoshimasa Nakano
Michiharu Sugawara
Setsuyoshi Uetsuki
Taketoshi Izawa
Tomoyuki Kawaguchi
Akira Wada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP63200928A priority Critical patent/JPH01131177A/ja
Publication of JPH01131177A publication Critical patent/JPH01131177A/ja
Publication of JPH0557273B2 publication Critical patent/JPH0557273B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/165—Heterorings having nitrogen atoms as the only ring heteroatoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP63200928A 1987-08-11 1988-08-10 Ｎｆ−１６１６−９０４物質 Granted JPH01131177A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63200928A JPH01131177A (ja) 1987-08-11 1988-08-10 Ｎｆ−１６１６−９０４物質

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP62-201537 1987-08-11
JP20153787 1987-08-11
JP63200928A JPH01131177A (ja) 1987-08-11 1988-08-10 Ｎｆ−１６１６−９０４物質

Publications (2)

Publication Number Publication Date
JPH01131177A JPH01131177A (ja) 1989-05-24
JPH0557273B2 true JPH0557273B2 (enExample) 1993-08-23

Family

ID=16442692

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63200928A Granted JPH01131177A (ja) 1987-08-11 1988-08-10 Ｎｆ−１６１６−９０４物質

Country Status (9)

Country Link
US (1) US5021419A (enExample)
EP (1) EP0303250B1 (enExample)
JP (1) JPH01131177A (enExample)
KR (1) KR960005150B1 (enExample)
CN (1) CN1028655C (enExample)
DE (1) DE3880231T2 (enExample)
DK (1) DK170617B1 (enExample)
ES (1) ES2054748T3 (enExample)
MX (1) MX9202936A (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238938A (en) * 1989-02-10 1993-08-24 Otsuka Pharmaceutical Co., Ltd. Indole derivatives
WO1990009380A1 (fr) 1989-02-10 1990-08-23 Otsuka Pharmaceutical Co., Ltd. Derives d'indole, leur preparation et medicament les contenant destine a la prevention et au traitement de la nephrite
TW197429B (enExample) * 1991-05-01 1993-01-01 Dtsuka Seiyaku Kk
SE529897C2 (sv) 2006-03-27 2007-12-27 Rottneros Ab Formpressat tråg

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427735D0 (en) * 1984-11-02 1984-12-12 Fujisawa Pharmaceutical Co Piperazine compound

Also Published As

Publication number Publication date
CN1028655C (zh) 1995-05-31
US5021419A (en) 1991-06-04
JPH01131177A (ja) 1989-05-24
DK170617B1 (da) 1995-11-13
DE3880231D1 (de) 1993-05-19
CN1032031A (zh) 1989-03-29
KR890003734A (ko) 1989-04-17
DK446388D0 (da) 1988-08-10
MX9202936A (es) 1992-06-30
EP0303250B1 (en) 1993-04-14
ES2054748T3 (es) 1994-08-16
KR960005150B1 (ko) 1996-04-22
EP0303250A3 (en) 1990-07-11
DK446388A (da) 1989-02-12
DE3880231T2 (de) 1993-10-07
EP0303250A2 (en) 1989-02-15

Similar Documents

Publication Publication Date Title
JP4095772B2 (ja) 新規生理活性物質スルフォスチン、その製造法及びその用途
JPWO1999025719A1 (ja) 新規生理活性物質スルフォスチン、その製造法及びその用途
JPH06339390A (ja) Ｂｕ−４１６４ｅ−ａ及びｂ、プロリルエンドペプチダーゼインヒビター
US4537858A (en) Plastatin
JPH0557273B2 (enExample)
US5801143A (en) Cyclic depsipeptides useful for treatment of hyperlipemia
RU2221870C2 (ru) Мумбайстатин, способ его получения и его применение в качестве фармацевтического препарата
JPH01149766A (ja) インドール誘導体
WO2000053792A1 (en) Substances wk-5344a and wk-5344b and process for producing the same
JPH1045738A (ja) 抗生物質エポキシキノマイシンｃおよびｄとその製造法ならびに抗リウマチ剤
US5232942A (en) Q-2819 substance and the use thereof
JP2810752B2 (ja) 新規生理活性物質サイクロオクタチン、その製造法およびその用途
JP3686693B2 (ja) 新規生理活性物質ベラクチンａおよびｂとその製造法
JP3435741B2 (ja) 新規物質及び該物質を生産する微生物
JPH0959275A (ja) 新規物質トリプロスタチン、その製造方法、細胞周期阻害剤および抗腫瘍剤
JP2546239B2 (ja) 新規物質オバリシン
JPH02258724A (ja) 新規抗生物質ｒｋ―２８６ｃ、その製造法並びに抗腫瘍剤及び抗炎症剤
CA2214871C (en) Process for preparing spirolaxine and spirolaxine methyl ether
JP2826140B2 (ja) 血小板活性化因子拮抗物質フォマクチンａ
JPH051777B2 (enExample)
JPH02288890A (ja) 新規生理活性物質ｏｆ４９４９及びその製造法
JP2001524092A (ja) コダイスタチンａ、ｂ、ｃおよびｄ、これらの化合物の製法および使用
JPH07278055A (ja) 抗菌性物質ｂｅ−４０６６５類
JPH064634B2 (ja) 新規化合物ｗｆ１３６０類、その製造法およびその用途
JP2000026468A (ja) ヒト免疫不全ウイルス増殖阻害物質およびそれらの製造方法